Shai Meretzki News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Shai meretzki. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Shai Meretzki Today - Breaking & Trending Today

Biotech firm grows bone from your own tissue for seamless healing

Bonus Biogroup says it has created a way of growing your own bones in a lab - and aims to bring its innovation to the market in a few years ....

Israel General , Tel Aviv , Ben Gurion , State Of Israel , Shai Meretzki , Barzilai Medical Center , Tel Aviv Stock Exchange , Business Development , Drug Administration , Bonus Biogroup , Tomer Bronstein , Tel Aviv Stock , Cell Therapy Biotech Innovation Award , Advanced Therapies Week ,

Artificial veins could boost success of organ transplants

Artificial veins could boost success of organ transplants
israel21c.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from israel21c.org Daily Mail and Mail on Sunday newspapers.

Shai Meretzki , Business Development At Bonus Biogroup , Bonus Biogroup , Business Development , Bonus Therapeutics ,

Israeli Covid drug also aids cancer immunotherapy patients

Bonus BioGroup’s MesenCure drug shown to lower the inflammatory overreaction in cancer patients that can cause multisystem failure. ....

United States , Shai Meretzki , Jackson Laboratory , Bonus Biogroup , Bonus Biogroup , Covid 19 ,

‏Bonus BioGroup's COVID Drug - MesenCure - Can Help a Life-threatening Complication Seen in Cancer Patients

/PRNewswire/ Haifa-based Biotech company, Bonus BioGroup (TASE: BONS), has recently completed a preclinical trial demonstrating the efficacy of its drug. ....

United States , Yaara Hames Ezra , Shai Meretzki , Jackson Laboratory , Bonus Biogroup ,

‏Bonus BioGroup's COVID Drug - MesenCure - Can Help a Life-threatening Complication Seen in Cancer Patients

/PRNewswire/ Haifa-based Biotech company, Bonus BioGroup (TASE: BONS), has recently completed a preclinical trial demonstrating the efficacy of its drug. ....

United States , Yaara Hames Ezra , Shai Meretzki , Jackson Laboratory , Bonus Biogroup ,